Intestinal Disease Education and Awareness Society IDEAS -
Ensemble Therapeutics Presents Oral Efficacy of First-in-Class Small Molecule ...MarketWatch (press release)... the company's Ensemblins have strong oral activity as antagonists of IL-17, a pro-inflammatory cytokine implicated in multiple inflammat...
The post Ensemble Therapeutics Presents Oral Efficacy appeared first on Intestinal Disease Education and Awareness Society IDEAS.